背景 医学疗法和VICTORIA试验的临床结果
Justin A Ezekowitz1, Ciaran J McMullan2, Cynthia M Westerhout1
1Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada (J.A.E., C.M.W., P.W.A.).
Circulation. Heart failure
|July 7, 2023
概括
韦里西瓜特在减少心血管死亡或心力衰竭住院治疗心力衰竭患者的心力衰竭和降低射出分数方面表现出一致的有效性,无论背景药物坚持如何. 这一发现支持其在各种患者治疗场景中的应用.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭管理涉及指南导向医学治疗 (GDMT).
- 患者对GDMT的坚持可能会有所不同,可能会影响治疗结果.
- 在VICTORIA试验中,对HFrEF患者进行了评估.
研究的目的:
- 评估背景GDMT使用和剂量与VICTORIA试验中初级复合结果之间的关系.
- 评估对关键HFrEF药物的坚持,包括ACE抑制剂,ARBs,RNAIs,β-阻断剂和MRAs.
- 为了确定输送者瓜特的治疗效果是否根据遵守GDMT而有所不同.
主要方法:
- 根据基本指标,指示纠正指标和剂量纠正指标评估了对GDMT的遵守.
- 用多变量调整分析了受试者治疗和依从组之间的主要结果之间的关联.
- 报告了具有95%置信区间 (CI) 和P相互作用值的危险比率 (HR).
主要成果:
- 大多数GDMT类的基本和指示校正依从率较高.
- 剂量调整后的坚持有所不同,ACE抑制剂/ARB/RNAI和β-阻断剂的比例较低.
- 对初级复合结果的 vericiguat 的治疗效果在所有坚持水平上都是一致的,没有显著的治疗异质性.
结论:
- 在VICTORIA试验中的患者通常接受了管理良好的HFrEF药物.
- 无论背景治疗是否坚持,Vericiguat的疗效都是一致的,即使考虑到说明,禁忌和耐受性.
- 这些发现支持了在广泛的HFrEF群体中, vericiguat的可靠有效性.
相关概念视频
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:28Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
202
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
202
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K